Evidence map›Paper›PMID 31937722›Full record

ArticleIndian journal of ophthalmology2020

Overview and project highlights of an initiative to integrate diabetic retinopathy screening and management in the public health system in India.

G V S Murthy, Clare Gilbert, Rajan Shukla, Vidyadhar Bala, Gaurang G Anirudh, Sridivya Mukpalkar, Pavani Yamarthi, Suneetha Pendyala, Anusha Puppala, Edla Supriya and 2 more

Open access · diamondAbstract readMulticenter Study
In one paragraph

Article in Indian journal of ophthalmology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

G V S MurthyInternational Centre for Eye Health, Clinical Research Department, London School for Hygiene and Tropical Medicine, London, UK; Indian Institute of Public Health, Public Health Foundation of India, Hyderabad, Telangana, India.
Clare GilbertInternational Centre for Eye Health, Clinical Research Department, London School for Hygiene and Tropical Medicine, London, UK.
Rajan ShuklaIndian Institute of Public Health, Public Health Foundation of India, Hyderabad, Telangana, India.
Vidyadhar BalaIndian Institute of Public Health, Public Health Foundation of India, Hyderabad, Telangana, India.
Gaurang G AnirudhIndian Institute of Public Health, Public Health Foundation of India, Hyderabad, Telangana, India.
Sridivya MukpalkarIndian Institute of Public Health, Public Health Foundation of India, Hyderabad, Telangana, India.
Pavani YamarthiIndian Institute of Public Health, Public Health Foundation of India, Hyderabad, Telangana, India.
Suneetha PendyalaIndian Institute of Public Health, Public Health Foundation of India, Hyderabad, Telangana, India.
Anusha PuppalaIndian Institute of Public Health, Public Health Foundation of India, Hyderabad, Telangana, India.
Edla SupriyaIndian Institute of Public Health, Public Health Foundation of India, Hyderabad, Telangana, India.
Tripura BatchuIndian Institute of Public Health, Public Health Foundation of India, Hyderabad, Telangana, India.
India DR Partners Implementation ConsortiumIndia DR Program Implementation.
Institute of Public Health · INLondon School of Hygiene & Tropical Medicine · GBPublic Health Foundation of India · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Diabetes is a public health concern in India and diabetic retinopathy (DR) is an emerging cause of visual impairment and blindness. Approximately 3.35-4.55 million people with diabetes mellitus (PwDM) are at risk of vision-threatening DR (VTDR) in India. More than 2/3 of India's population resides in rural areas where penetration of modern medicine is mostly limited to the government public health system. Despite the increasing magnitude, there is no systematic screening for the complications of diabetes, including DR in the public health system. Therefore, a pilot project was initiated with the major objectives of management of DR at all levels of the government health system, initiating a comprehensive program for the detection of eye complications among PwDM at public health noncommunicable disease (NCD) clinics, augmenting the capacity of physicians, ophthalmologists and health support personnel and empowering carers/PwDM to control the risk of DR through increased awareness and self-management. Methods: A national task force (NTF) was constituted to oversee policy formulation and provide strategic direction. 10 districts were identified for implementation across 10 states. Protocols were developed to help implement training and service delivery. Results: Overall, 66,455 PwDM were screened and DR was detected in 16.2% (10,765) while VTDR was detected in 7.5%. 10.1% of those initially screened returned for the next annual assessment. There was a 7-fold increase in the number of PwDM screened and a 7.6-fold increase in the number of PwDM treated between 2016 and 2018. Conclusion: Services for detecting and managing DR can be successfully integrated into the existing public health system.

Indexed as

Health Knowledge, Attitudes, PracticePopulation SurveillancePublic HealthDiabetic RetinopathyFemaleHumansIndiaMaleMass ScreeningMorbidityPilot ProjectsRetrospective StudiesRisk FactorsDiabetesdiabetic retinopathyhealth systemsIndiaintegrationvisual impairment

Identifiers

PMID31937722
PMCPMC7001184
OpenAlexW2999928623

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.